We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OTC Drug Firm Cited for cGMPs And Lack of New Drug Approval
OTC Drug Firm Cited for cGMPs And Lack of New Drug Approval
April 2, 2007
The FDA cited Niagara Pharmaceuticals for distributing its private label OTC sterile eyewash preparations without an approved new drug
application and for violating cGMPs.